ClinicalTrials.Veeva

Menu

Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases

S

Schön Klinik Berchtesgadener Land

Status

Completed

Conditions

COPD
Interstitial Lung Disease

Treatments

Device: conventional nasal cannula
Device: Oxymizer

Study type

Interventional

Funder types

Other

Identifiers

NCT01713413
OXYM2012

Details and patient eligibility

About

The Oxymizer pendant® is a special oxygen cannula that can be used to supply high flow long term oxygen therapy. It is compatible with a wide variety of oxygen sources. In a reservoir, the Oxymizer® stores pure oxygen so that the concentration of inhaled oxygen is increased.

The aim of this study is to investigate the potential benefit of the Oxymizer® with regard to the blood oxygenation during exercise testing. Given that the "endurance time" is very sensitive for little changes in exercise capacity, this test will be used to show the difference between the Oxymizer® and a conventional nasal cannula regarding exercise duration at 70% of peak Watt and oxygenation.

The tests will be accompanied by blood gas analysis, partial pressure of carbon dioxide and heart rate.

Enrollment

67 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD IV
  • interstitial lung disease
  • long-term oxygen therapy with oxygen flow rate >= 2 L/min

Exclusion criteria

  • acute cardial decompensation
  • usual kontraindication for exposure test (higher-grad Hypertension (arterial and pulmonal), cardiac valve vitien, instabile angina pectoris, cardiac arrhythmia)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

67 participants in 2 patient groups

Oxymizer
Active Comparator group
Description:
Using first the Oxymizer and 24 h later the conventional nasal cannula.
Treatment:
Device: Oxymizer
nasal cannula
Active Comparator group
Description:
Using first the conventional nasal cannula and 24 h later the Oxymizer
Treatment:
Device: conventional nasal cannula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems